Inhibition of interleukin-1 type I receptor expression in human cell-lines by an antisense phosphorothioate oligodeoxynucleotide

Loren Miraglia(Genomics Institute of the Novartis Research Foundation), Nicholas M. Dean(Centre d'Investigation Clinique de Nantes), Thomas Geiger(Novartis (Switzerland)), C. Frank Bennett(Pennsylvania State University)
International Journal of Immunopharmacology
April 1, 1996
Cited by 13


Related Papers